AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
Eli Lilly CEO: The Weight-Loss Drug Revolution, AI in Pharma, and Innovation
In Good Company with Nicolai Tangen
Intro
This chapter explores the advancements in weight-reducing medications, particularly GLP-1 agonists, and their effectiveness in treating obesity and other health issues. The discussion highlights the evolution of these drugs, from their inception to innovative formulations, and their significant impact on metabolic and neurological health.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode